Description

Researchers have iterated that the future of synthetic biology and biotechnology lies in novel consumer applications of crossing biology with engineering. However, if the new biology's future is to be

Researchers have iterated that the future of synthetic biology and biotechnology lies in novel consumer applications of crossing biology with engineering. However, if the new biology's future is to be sustainable, early and serious efforts must be made towards social sustainability. Therefore, the crux of new applications of synthetic biology and biotechnology is public understanding and acceptance. The RASVaccine is a novel recombinant design not found in nature that re-engineers a common bacteria ( Salmonella) to produce a strong immune response in humans.

application/pdf

Download count: 0

Details

Contributors
Date Created
  • 2014-08-01
Resource Type
  • Text
  • Collections this item is in
    Identifier
    • Digital object identifier: 10.1007/s11569-014-0198-6
    • Identifier Type
      International standard serial number
      Identifier Value
      1871-4757
    • Identifier Type
      International standard serial number
      Identifier Value
      1871-4765
    Note

    Citation and reuse

    Cite this item

    This is a suggested citation. Consult the appropriate style guide for specific citation guidelines.

    Dankel, Dorothy J., Roland, Kenneth L., Fisher, Michael, Brenneman, Karen, Delgado, Ana, Santander, Javier, Baek, Chang-Ho, Clark-Curtiss, Josephine, Strand, Roger, & Curtiss, Roy, III (2014). Making Common Sense of Vaccines: An Example of Discussing the Recombinant Attenuated Salmonella Vaccine with the Public. NANOETHICS, 8(2), 179-185. http://dx.doi.org/10.1007/s11569-014-0198-6

    Machine-readable links